# Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer

> **NCT07730541** · — · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Neoadjuvant Chemoradiotherapy

## Interventions

- **DRUG:** Hyperpolarized 13C-MRI (HP 13C-MRI)

## Key facts

- **NCT ID:** NCT07730541
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-07-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730541, "Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*